H-CYTE, Inc. (HCYT) は上場企業です ヘルスケア セクターの バイオテクノロジー 業界で事業展開. 本社所在地は Tampa, FL, アメリカ. 現CEOは Michael W. Yurkowsky.
HCYT を有する IPO日 2014-12-19, 2 名の正社員, に上場 Other OTC, 時価総額 $624.98K.
H-CYTE, Inc., a biopharmaceutical company, develops and delivers various treatments for patients with chronic respiratory and pulmonary disorders in the United States. The company develops and implements treatment options in autologous cellular therapy to treat chronic lung disorders. It has a product supply agreement with Rion, LLC to develop and distribute a biologic for chronic obstructive pulmonary disease. The company is headquartered in Tampa, Florida.
